What is the actual quantitative contribution of FcRn-mediated transcytosis to BBB antibody transport in humans?

The debate revealed conflicting estimates ranging from <5% to 20% for FcRn's role in BBB transport, with species differences unresolved. This fundamental uncertainty undermines rational design of FcRn-targeted therapeutics and dosing strategies.

Created: 2026-04-16
Download .ipynb